Intellectual Property India Publishes Patent Application for 'Methods And Platform Involving The Use Of A Nucleo-Cytoplasmic Form Of Protein Lysine Methyltransferase Ehmt1 N/C' Filed by Institute For Stem Cell Science And Regenerative Medicine; and Council Of Scientific And Industrial Research

MUMBAI, India, Oct. 31 -- Intellectual Property India has published a patent application (202547094324 A) filed by Institute For Stem Cell Science And Regenerative Medicine; and Council Of Scientific And Industrial Research, Bengaluru, India, on Oct. 1, for 'methods and platform involving the use of a nucleo-cytoplasmic form of protein lysine methyltransferase ehmt1 n/c.'

Inventor(s) include Deshpande, Shravanti Rampalli; and Biligiri, Kriti Kestur.

The application for the patent was published on Oct. 31, under issue no. 44/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure relates to a a method of modulating the activity of EHMT1 N/C and its role as a pro-viral factor at the interface of...